Pharma menace Martin Shkreli's old company to pay up to $40M to states for Daraprim price gouging

Zachary Brennan

Senior Editor

The Federal Trade Commission and seven states on Tuesday announced a new order under which the states will recoup $40 million from pharma badboy Martin …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Pharma menace Martin Shkreli's old company to pay up to $40M to states for Daraprim price gouging

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Phar­ma men­ace Mar­tin Shkre­li's old com­pa­ny to pay up to $40M to states for Dara­prim price goug­ing

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Pharma menace Martin Shkreli's old company to pay up to $40M to states for Daraprim price gouging